Dysregulation of HOX as a Potential Therapeutic Target in Breast Cancer
-
Published:2021-08-16
Issue:25
Volume:28
Page:5084-5097
-
ISSN:0929-8673
-
Container-title:Current Medicinal Chemistry
-
language:en
-
Short-container-title:CMC
Author:
Lee Ji-Yeon1ORCID,
Kim Myoung Hee1ORCID
Affiliation:
1. Department of Anatomy, Embryology Laboratory, Yonsei University College of Medicine, Seoul, Korea
Abstract
HOX genes belong to the highly conserved homeobox superfamily, responsible
for the regulation of various cellular processes that control cell homeostasis, from embryogenesis
to carcinogenesis. The abnormal expression of HOX genes is observed in
various cancers, including breast cancer, where they act as oncogenes or as suppressors
of cancer, according to context. In this review, we analyze HOX gene expression patterns
in breast cancer and examine their relationship, based on the three-dimensional genome
structure of the HOX locus. The presence of non-coding RNAs embedded within the
HOX cluster and the role of these molecules in breast cancer, have been reviewed. We
further evaluate the characteristic activity of HOX protein in breast cancer and its therapeutic
potential.
Funder
"Ministry of Education, Science and Technology-Basic Science Research Program through the National Research Foundation (NRF)"
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献